Currently out of the existing stock ratings of Graham Doyle, 5 are a SELL (23.81%), 11 are a HOLD (52.38%), 5 are a BUY (23.81%).

Graham Doyle

Work Performance Price Targets & Ratings Chart

Analyst Graham Doyle, currently employed at UBS, carries an average stock price target met ratio of 40% that have a potential upside of 24.94% achieved within 115 days.

Graham Doyle’s has documented 36 price targets and ratings displayed on 5 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on SNN, Smith & Nephew SNATS at 05-Jun-2024.

Wall Street Analyst Graham Doyle

Analyst best performing recommendations are on PHG (KONINKLIJKE PHILIPS NV ADR).
The best stock recommendation documented was for PHG (KONINKLIJKE PHILIPS NV ADR) at 9/2/2022. The price target of $16.49 was fulfilled within 7 days with a profit of $1.5 (10.01%) receiving and performance score of 14.3.

Average potential price target upside

SNN Smith & Nephew SNATS PHG Koninklijke Philips NV ADR FMS Fresenius Medical Care FSNUY Fresenius SE KGaA ADR ALC Alcon AG

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$24.5

1 months 16 days ago
(06-Nov-2024)

8/9 (88.89%)

$-6.92 (-22.02%)

499

Hold

6 months 17 days ago
(05-Jun-2024)

0/3 (0%)

$-11.75 (-46.78%)

Buy

$15.29

$-9.37 (-38.00%)

$15.07

1 years 1 months 19 days ago
(03-Nov-2023)

3/14 (21.43%)

$-8.79 (-36.50%)

504

Buy

$33

$8.34 (33.82%)

$39.5

1 years 2 months 18 days ago
(04-Oct-2023)

0/2 (0%)

$9.53 (40.61%)

Buy

$16.94

$-7.72 (-31.31%)

$14.12

1 years 8 months 11 days ago
(11-Apr-2023)

0/3 (0%)

$-11.96 (-41.38%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Graham Doyle?

On 2022

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?